Literature DB >> 16787155

Utility of mass spectrometry for pharmaceutical profiling applications.

Edward H Kerns1, Li Di.   

Abstract

MS has great utility for pharmaceutical profiling, the measurement of physicochemical and metabolic properties that are crucial to the discovery and development of new drug candidates. An evaluation of the capabilities of MS to improve the speed, specificity, sensitivity and cost per compound of method in development indicates when MS technologies have utility compared to other analytical techniques. MS has been used successfully for methods that profile the critical properties: permeability, lipophilicity, plasma and solution stability, solubility, plasma protein binding and integrity. In general, MS has utility in these methods using analytical strategies involving unique MS technologies (e.g., parallel multiplexed interfaces, trap-and-elute), orthogonal detection to UV, high sensitivity for low LOQs, low concentration studies, highly specific MS/MS SRM, combinatorial analysis, use of internal standards, providing initial structural data in addition to quantitative and facile integration with HPLC autosamplers and other hardware that allow enhanced on-line experiments. Ultimately, it is important to evaluate the appropriateness of any technique that is being considered for use in a method, to insure that it best meets all of the criteria for the organization's needs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16787155     DOI: 10.2174/138920006777697981

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  3 in total

Review 1.  Analytical challenges translating mass spectrometry-based phosphoproteomics from discovery to clinical applications.

Authors:  Anton B Iliuk; Justine V Arrington; Weiguo Andy Tao
Journal:  Electrophoresis       Date:  2014-07-10       Impact factor: 3.535

Review 2.  Current status and future directions of high-throughput ADME screening in drug discovery.

Authors:  Wilson Z Shou
Journal:  J Pharm Anal       Date:  2020-05-23

3.  A Fully Integrated Assay Panel for Early Drug Metabolism and Pharmacokinetics Profiling.

Authors:  Johan Wernevik; Fredrik Bergström; Anna Novén; Johan Hulthe; Linda Fredlund; Dan Addison; Jan Holmgren; Per-Erik Strömstedt; Erika Rehnström; Thomas Lundböck
Journal:  Assay Drug Dev Technol       Date:  2020-05-14       Impact factor: 1.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.